| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $452.4M | +36.0% |
| Cost of Revenue | $77.9M | +43.2% |
| R&D Expense | $95.1M | +51.7% |
| SG&A Expense | $78.7M | -3.3% |
| Operating Income | $59.0M | +121.2% |
| Interest Expense | $905K | -22.8% |
| Pre-tax Income | $59.4M | +129.9% |
| Income Tax | $16.1M | +561.7% |
| Net Income | $43.3M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $267.8M | +20.9% |
| Accounts Receivable | $167.1M | +35.9% |
| Current Assets | $445.1M | +21.0% |
| Total Assets | $1.04B | +16.2% |
| Current Liabilities | $68.9M | +20.8% |
| Total Liabilities | $160.2M | +72.0% |
| Stockholders' Equity | $876.9M | +9.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $94.9M | +14.6% |
| Capital Expenditures | $40.0M | +325.5% |
| Investing Cash Flow | -$40.0M | +74.8% |
| Financing Cash Flow | -$7.9M | -103.0% |
| Free Cash Flow | $54.9M | -25.2% |
| +47.6% |
| EPS (Basic) | $0.26 | +30.0% |
| EPS (Diluted) | $0.25 | +38.9% |